L-type calcium channel blockade on haloperidol-induced c-Fos expression in the striatum
- PMID: 17913375
- DOI: 10.1016/j.neuroscience.2007.08.013
L-type calcium channel blockade on haloperidol-induced c-Fos expression in the striatum
Abstract
Haloperidol-induced c-Fos expression in the lateral part of the neostriatum has been correlated with motor side effects while c-Fos induction in the medial part of the neostriatum and the nucleus accumbens is thought to be associated with the therapeutic effects of the drug. Induction of c-Fos in the striatum by haloperidol involves dopamine D(2) (DA D(2)) receptor antagonism and is dependent on activation of N-methyl-d-aspartate (NMDA) receptors and L-type Ca(2+) channels. In the current study, pretreatment with L-type Ca(2+) channel blockers suppressed haloperidol-induced c-Fos throughout the neostriatum and the nucleus accumbens at 2 h postinjection. However, elevated c-Fos protein expression was observed only in the lateral part of the neostriatum at 5 h postinjection of haloperidol following pretreatment of L-type Ca(2+) channel blocker compared with rats pretreated with vehicle alone. In addition, pretreatment prolonged the duration of haloperidol-induced catalepsy in rats. Infusions of L-type Ca(2+) channel blockers directly into the neostriatum mimicked similar patterns of changes in haloperidol-induced c-Fos expression. Prolonged expression of c-Fos was not observed following coadministration of nifedipine and a dopamine D(1) (DA D(1)) receptor agonist, SKF 81297, but could be mimicked by the DA D(2/3) receptor antagonist raclopride, suggesting that the phenomenon is likely related to DA D(2) receptor antagonism. Moreover, the expression levels of haloperidol-induced zif 268 and haloperidol-induced phosphorylated CREB and phosphorylated Elk-1 were also substantially elevated for a prolonged period of time in the lateral, but not the medial part of the neostriatum, following blockade of L-type Ca(2+) channels. Collectively, the results suggest that coadministration of L-type Ca(2+) channel blockers affects haloperidol signaling in the lateral part of the neostriatum and may exacerbate the development of acute motor side effects.
Similar articles
-
F15063, a potential antipsychotic with dopamine D(2)/D(3) receptor antagonist and 5-HT(1A) receptor agonist properties: influence on immediate-early gene expression in rat prefrontal cortex and striatum.Eur J Pharmacol. 2009 Oct 12;620(1-3):27-35. doi: 10.1016/j.ejphar.2009.08.019. Epub 2009 Aug 18. Eur J Pharmacol. 2009. PMID: 19695244
-
Chronic food restriction increases D-1 dopamine receptor agonist-induced phosphorylation of extracellular signal-regulated kinase 1/2 and cyclic AMP response element-binding protein in caudate-putamen and nucleus accumbens.Neuroscience. 2004;125(1):289-98. doi: 10.1016/j.neuroscience.2004.01.037. Neuroscience. 2004. PMID: 15051167
-
Role of adenosine and N-methyl-D-aspartate receptors in mediating haloperidol-induced gene expression and catalepsy.J Pharmacol Exp Ther. 1999 Nov;291(2):531-7. J Pharmacol Exp Ther. 1999. PMID: 10525068
-
Neuroanatomical targets of neuroleptic drugs as revealed by Fos immunochemistry.J Clin Psychiatry. 1994 Sep;55 Suppl B:33-6. J Clin Psychiatry. 1994. PMID: 7961569 Review.
-
Involvement of signal transduction cascade via dopamine-D1 receptors in phencyclidine dependence.Ann N Y Acad Sci. 2004 Oct;1025:62-8. doi: 10.1196/annals.1316.008. Ann N Y Acad Sci. 2004. PMID: 15542701 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous